Matt Jenkins

Matt Jenkins is a Partner at QHP Capital, where expertise in investing in life sciences and pharma services is applied. Current board memberships include Univo IRB, Applied StemCell, AutoCruitment, Clinical ink, and Lexitas Pharma Services, Inc., focusing on ethical review boards, gene therapy, patient recruitment for clinical trials, data technology integration, and ophthalmic biopharmaceutical solutions, respectively. Previously, Matt served as Head of Corporate Development & Private Equity Investments at RTI International and held board observer and investor roles at Seven Bridges, BioIQ, and PierianDx. Educational qualifications include a B.S. in Business Administration from the University of North Carolina at Chapel Hill and an MBA in Finance from UNC Kenan-Flagler Business School.